Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
 BACK TO LIST

Laboratory Report

Patient
Name: Meléndez, María Manuela
DOB: 01-AUG-1982 (Age: 43)
Gender: female
Address:
Pasadizo de Samanta Valenzuela 29
05001 Ávila (Spain)
ID: 3014-208609-6 (ECI)
Report
Date: 05-MAY-2019
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Hospital Provincial - CAÁvila
05003 Ávila (Spain)
Specimen
Collected: 05-MAY-2019

Chemistry

Test 05-MAY-2019 Reference Range Unit
Cholesterol [Mass/volume] in Serum or Plasma 221.2 H 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 121.5 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 137.9 H 0 - 100 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 59.0 40 - 60 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows mildly elevated total cholesterol and LDL cholesterol, while triglycerides and HDL cholesterol are within normal limits. These findings suggest an increased cardiovascular risk. Lifestyle modifications and further clinical assessment are recommended to address dyslipidemia.